Teva CEO Discusses Q2 Earnings and NYSE Direct Listing

Teva Pharmaceuticals CEO Richard Francis spoke about the company's positive second-quarter earnings, the upcoming impact of changes to Medicare rules on patients, and the company's planned direct listing on the New York Stock Exchange.